Moderna Inc. lashed out at the US Food and Drug Administration for making it harder for companies to create new medicines, escalating a dispute between the vaccine maker and the regulator.
A new case report was published in Volume 17 of Oncotarget on February 6, 2026, titled “Exploring the potential link between ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results